Literature DB >> 19656488

Intestinal cholecystokinin controls glucose production through a neuronal network.

Grace W C Cheung1, Andrea Kokorovic, Carol K L Lam, Madhu Chari, Tony K T Lam.   

Abstract

Cholecystokinin (CCK) is a peptide hormone that is released from the gut in response to nutrients such as lipids to lower food intake. Here we report that a primary increase of CCK-8, the biologically active form of CCK, in the duodenum lowers glucose production independent of changes in circulating insulin levels. Furthermore, we show that duodenal CCK-8 requires the activation of the gut CCK-A receptor and a gut-brain-liver neuronal axis to lower glucose production. Finally, duodenal CCK-8 fails to lower glucose production in the early onset of high-fat diet-induced insulin resistance. These findings reveal a role for gut CCK that lowers glucose production through a neuronal network and suggest that intestinal CCK resistance may contribute to hyperglycemia in response to high-fat feeding.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19656488     DOI: 10.1016/j.cmet.2009.07.005

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   27.287


  73 in total

1.  Cholecystokinin is up-regulated in obese mouse islets and expands beta-cell mass by increasing beta-cell survival.

Authors:  Jeremy A Lavine; Philipp W Raess; Donald S Stapleton; Mary E Rabaglia; Joshua I Suhonen; Kathryn L Schueler; James E Koltes; John A Dawson; Brian S Yandell; Linda C Samuelson; Margery C Beinfeld; Dawn Belt Davis; Marc K Hellerstein; Mark P Keller; Alan D Attie
Journal:  Endocrinology       Date:  2010-06-09       Impact factor: 4.736

Review 2.  Diet: friend or foe of enteroendocrine cells--how it interacts with enteroendocrine cells.

Authors:  Sofia Moran-Ramos; Armando R Tovar; Nimbe Torres
Journal:  Adv Nutr       Date:  2012-01-05       Impact factor: 8.701

3.  The cholecystokinin-1 receptor antagonist devazepide increases cholesterol cholelithogenesis in mice.

Authors:  Helen H Wang; Piero Portincasa; David Q-H Wang
Journal:  Eur J Clin Invest       Date:  2016-01-12       Impact factor: 4.686

Review 4.  T1R and T2R receptors: the modulation of incretin hormones and potential targets for the treatment of type 2 diabetes mellitus.

Authors:  Cedrick D Dotson; Stephan Vigues; Nanette I Steinle; Steven D Munger
Journal:  Curr Opin Investig Drugs       Date:  2010-04

Review 5.  Immunologic impact of the intestine in metabolic disease.

Authors:  Daniel A Winer; Shawn Winer; Helen J Dranse; Tony K T Lam
Journal:  J Clin Invest       Date:  2017-01-03       Impact factor: 14.808

6.  Lipid transport in cholecystokinin knockout mice.

Authors:  Alexandra King; Qing Yang; Sarah Huesman; Therese Rider; Chunmin C Lo
Journal:  Physiol Behav       Date:  2015-07-11

Review 7.  Hypothalamic control of energy and glucose metabolism.

Authors:  Stephanie Sisley; Darleen Sandoval
Journal:  Rev Endocr Metab Disord       Date:  2011-09       Impact factor: 6.514

Review 8.  Roles for gut vagal sensory signals in determining energy availability and energy expenditure.

Authors:  Gary J Schwartz
Journal:  Brain Res       Date:  2018-08-15       Impact factor: 3.252

Review 9.  Diversity of enteroendocrine cells investigated at cellular and subcellular levels: the need for a new classification scheme.

Authors:  Linda J Fothergill; John B Furness
Journal:  Histochem Cell Biol       Date:  2018-10-24       Impact factor: 4.304

10.  mTOR Signaling in X/A-Like Cells Contributes to Lipid Homeostasis in Mice.

Authors:  Ziru Li; Ruili Yu; Wenzhen Yin; Yan Qin; Liangxiao Ma; Michael Mulholland; Weizhen Zhang
Journal:  Hepatology       Date:  2018-12-31       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.